DENVER —Attorney General John Suthers announced today that he and 37 other Attorneys General reached a $90 million settlement with GlaxoSmithKline LLC (NYSE: GSK) to resolve allegations that the drug manufacturer unlawfully promoted its diabetes drug, Avandia®. Under the consent judgment, of the total settlement, Colorado will receive $1.9 million in funds for failing to disclose all negative side effects.
